Alphatec Holdings, Inc. - ATEC STOCK NEWS

Alphatec Holdings, Inc. (ATEC) reported notable preliminary financial results for Q4 and FY 2022, with total revenue rising approximately 44% to over $350 million. The company predicts a 25% revenue growth in 2023, anticipating $438 million, alongside achieving break-even adjusted EBITDA. ATEC secured a $150 million non-dilutive term loan to bolster its balance sheet, enhancing liquidity to around $275 million. Surgical revenue increased by 48% to 50%, reflecting strong adoption of the PTP™ approach. The firm plans to continue expanding its market presence in spine surgery.

Alphatec Holdings, Inc. (NASDAQ: ATEC) announced its participation in the 25th Annual Needham Growth Conference with a fireside chat scheduled for January 12, 2023, at 3:00 PM ET. The presentation will be available via webcast in the Company’s Investor Relations Section.

Additionally, the Company granted 18,048 restricted stock units to 16 new employees as part of its employment inducement awards.

Alphatec Holdings, Inc. (ATEC) reported a strong 43% growth in total revenue, reaching $90 million for Q3 2022, driven by a 53% increase in surgical revenue. The company achieved a 66% GAAP gross margin and a 71% non-GAAP gross margin. Despite operating expenses of $94 million, adjusted EBITDA improved significantly, with a margin increase of 870 basis points year-over-year. ATEC anticipates total revenue of $340 million for the full year, in line with a 40% growth rate forecasted earlier.

Alphatec Holdings, Inc. (NASDAQ: ATEC) announced participation in several investor events aimed at discussing spine surgery innovations. Key events include a fireside chat at the Stifel 2022 Healthcare Conference on November 15, 2022, and the Jefferies London Healthcare Conference on November 17, 2022. Additionally, ATEC will present at the Piper Sandler Healthcare Conference on November 30, 2022, and host a visit from the Stifel Medtech Madness Annual West Coast Bus Tour on December 12, 2022. Webcasts and archived recordings will be accessible on the Investor Relations section of ATEC's website.

Alphatec Holdings, Inc. (ATEC) announced its participation in the 2022 NASS Annual Meeting, where it will unveil its new expandable interbody and access technology aimed at enhancing minimally-invasive spine surgery. This innovative approach minimizes muscle damage and blood loss, leading to shorter hospital stays and quicker recovery for patients. The Sigma Medialized Access System and PSX Expandable Interbody Implant System are designed to improve surgical outcomes by allowing precise control of spinal alignment and disc height restoration.

Alphatec Holdings, Inc. (NASDAQ: ATEC) has unveiled innovative advancements in its lateral spine surgery techniques at the 2022 NASS Annual Meeting. This includes enhancements to its Lateral TransPsoas (LTP^TM) and Midline ALIF^TM approaches, designed to improve patient outcomes and streamline surgical procedures. Key features involve a novel positioner and retractor integrated with SafeOp Neuromonitoring technology, aimed at minimizing complications during surgery. The company emphasizes its commitment to becoming a standard bearer in less invasive spine care.

Alphatec Holdings (NASDAQ: ATEC) reported preliminary financial results for Q3 2022, projecting total revenues between $89 million and $90 million, reflecting a growth of 42% to 43% year-over-year. Organic revenue is expected to rise by 51% to 53%, fueled by procedural volume growth exceeding 30%. The company has adjusted its full-year 2022 revenue guidance to approximately 40% growth, up from 34%. ATEC ends the quarter with about $106 million in cash.

Alphatec Holdings (NASDAQ: ATEC) announced its participation in the North American Spine Society (NASS) 37th Annual Meeting from October 12-15, 2022. The company will showcase its innovative spine surgery solutions, emphasizing advancements in lateral access surgery, including the Prone TransPsoas (PTP™) approach. Key presentations include topics on clinical distinction and the use of EOS imaging. The event aims to demonstrate how ATEC enhances clinical predictability and reproducibility in spine surgery. CEO Pat Miles expressed enthusiasm for their progress and future innovations.

Alphatec Holdings, Inc. (Nasdaq: ATEC) announced participation in three upcoming investor events. CFO Todd Koning and VP of Finance Robert Judd will engage in a fireside chat at the H.C. Wainwright 24th Annual Global Investment Conference on September 12, 2022, at 5:00 p.m. ET. They will also participate in the Morgan Stanley 20th Annual Global Healthcare Conference on September 13, 2022, at 4:05 p.m. ET, and the Lake Street Big 6 Conference on September 14, 2022. Webcasts will be available in the Investor Relations Section of the Company’s website.